Global telehealth to hit $6.5B by 2020

Beth Walsh | | Health Exec | Telehealth

The global telehealth market is expected to grow rapidly within the next five years and reach $6.5 billion by 2020, according to a Markets and Markets report. Currently valued at $2.2 billion, the market is expected to grow at a compound annual growth rate of 24.2 percent. 

The biggest drivers of the growth are the aging population, physician shortage, rising healthcare costs, improvement in telecommunication infrastructure and increasing awareness.

This year, North America is expected to have the largest market share, followed by Europe and Asia-Pacific. The Asia-Pacific market is the fastest growing segment.

Key players in the telehealth market include the following:

• Cerner
• Cisco Systems
• GE Healthcare
• Honeywell Life Care Solutions
• McKesson
• Medvivo Group
• Philips Healthcare
• Robert Bosch Healthcare
• Siemens Healthcare
• Tunstall Healthcare

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

Amazon One Medical sued after patient prescribed inhaler dies in ER
DEA, HHS extend telehealth controlled substance prescription rule
Association of 300 telehealth groups urges Congress to extend COVID-era rules
Eli Lilly releases cheaper, single-use vials of weight loss drug
Walmart sells virtual care business to Fabric
AMA will aggressively support permanent telemedicine reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.